 |
|
A CTN Annual Meeting was held September 10-13, 2001, in Arlington, Virginia. This was an opportunity to bring together researchers and practitioners that participate in the CTN to meet each other, network and interchange ideas and experiences. Multiple break out meetings were held for professional development and training. The meetings were cut short by the September 11th disasters. On October 22-24, 2001, the CTN Steering Committee met in Bethesda, MD. The members discussed future funding plans for new nodes, agreed on a common assessment battery instrument for all future CTN trials, approved new protocol teams, and met with managed health care providers. The CTN held its quarterly meeting of the Data & Safety Monitoring Board on Oct. 29, 2001 (postponed from Sept 17). The Board reviewed 6 current trials for safety and scientific integrity. Reports were presented on all Serious Adverse Events, and on the 6 trials’ progress. No protocol changes were recommended. Discussion will continue on procedures for reviewing new protocols. During the months of August – December, over 160 conference calls were held in the CCTN. These conference calls were held by national committees, subcommittees, and work groups within the network. Mr. Richard A. Millstein, NIDA Deputy Director, met with Drs. Joseph Autry, Acting Administrator, SAMHSA, and Ruth Sanchez-Way, Director of CSAP, on collaborations on prevention research and practice, October 10, 2001, Rockville, MD. A followup meeting of Mr. Millstein, Drs. Elizabeth Robertson and Jackie Kaftarian of DESPR, and Dr. Sanchez-Way and staff was held on February 11, 2002. Mr. Millstein gave two talks at the annual meeting of the American Public Health Association on “Drug Abuse Research: The Foundation for Policy” and “Bringing Research Knowledge to Community Practice,” October 22-24, 2001, Atlanta, GA. Mr. Millstein presented to the National Hispanic Science Network on “PAs, RFAs, and Strategies for Successful Grant Writing,” November 8, 2001, Washington, D.C. Mr. Millstein presented on DESPR programs and priorities at NIDA’s 7th Constituent Conference, December 3, 2001, Chantilly, VA. Mr. Millstein spoke to Leadership Montgomery on “What Science Tells Us About Drug Abuse”, December 5, 2001, Gaithersburg, MD. Dr. Timothy P. Condon, Associate Director, NIDA, presented and was a discussant at the Club Drug Use and Gay Men’s Health Colloquium of the American Psychological Association Convention in San Francisco, CA on August 24, 2001. Dr. Timothy P. Condon presented “Addiction as a Brain Disease: New Implications for Research and Practice” for the Connecticut Statewide Addiction Medicine/Psychiatry Grand Rounds interactive web broadcast on September 20, 2001. Dr. Timothy P. Condon presented “Blending Research and Practice: What Research Can Tell Us” at the Demand Treatment! Leadership Institute II in Denver, Colorado on September 24, 2001. Dr. Timothy P. Condon briefed two American Managed Behavioral Healthcare Organization member groups on the effectiveness of drug addiction treatment and on NIDA’s Clinical Trials Network on October 17, 2001 in Washington, D.C. Dr. Timothy P. Condon presented and led discussions on club drugs, the science of addiction, and drug abuse prevention and treatment strategies during a half day symposium entitled “Science Advances in the Emerging Drug Problem: Blending Research and Practice” at the Alcohol and Drug Abuse Division of the State of Hawaii Department of Health Conference in Honolulu, HI on October 23, 2001. Dr. Timothy P. Condon presented “Developmental Consequences of Prenatal Exposure to Drugs of Abuse” at the Intrauterine Effects of Substances of Abuse Institute of the 48th Annual Meeting of the American Academy of Child & Adolescent Psychiatry on October 24, 2001 in Honolulu, HI. Dr. Timothy P. Condon presented “Advances in Drug Abuse and Addiction Research: Implications for Criminal Justice Populations” at the Eighth National TASC Conference on Drugs and Crime on October 30, 2001 in Orlando, FL. Drs. Timothy P. Condon, OSPC, and Jerry Flanzer, DESPR, participated in Proposition 36: A Working Meeting on Research on November 9, 2001 in San Francisco, CA. Dr. Timothy P. Condon participated in the Robert Wood Johnson Foundation Substance Abuse Policy Research Program Annual Grantee Meeting on November 14, 2001 in St. Augustine, FL. Dr. Timothy P. Condon participated in the 2001 National Conference on Tobacco OR Health on November 27, 2001 in New Orleans, LA. Dr. Timothy P. Condon presented an “Update on Research Dissemination” at NIDA’s Seventh Constituent Conference in Chantilly, VA on December 4, 2001. Dr. Timothy P. Condon presented “Drug Abuse & Addiction: What’s New on the Research Scene” at the CADCA National Leadership Forum XII on December 13, 2001 in Washington, D.C. Dr. Jack Stein, Deputy Director, OSPC, participated in a plenary session “Practice Improvement: Bridging the Gap Between Practice and Research” at the Alcohol & Substance Abuse Providers of New York State 5th Annual Treatment Prevention Conference in Saratoga Springs, New York on October 23, 2001. Dr. Jack Stein conducted a half-day workshop on club drugs at the Annual Department of Education’s Alcohol and Drug Abuse Forum in Crystal City, Virginia on November 8, 2001. Dr. Jack Stein and Dr. Jerry Frankenheim, DNRB, conducted a workshop entitled “MDMA (Ecstasy) What Research is Telling Us” at the CADCA National Leadership Forum in Washington, DC on December 14, 2001. Dr. Cindy Miner, Chief, Science Policy Branch, OSPC, organized and presented “NIDA/NIMH Grantwriting Workshop and Mock IRG Panel” along with Dr. Cheryl Boyce, NIMH, at the American Academy of Child and Adolescent Psychiatry meeting, Friday, October 26, 2001 in Honolulu, Hawaii. This workshop was designed to familiarize child and adolescent psychiatrists with the NIH grants and review process. Dr. Cindy Miner gave a presentation on club drugs for the Gerber Adult Seminars, Science and Technology series on November 19, 2001 at the Jewish Community Center, Rockville, Maryland. Dr. Cindy Miner organized and presented along with Dr. Howard Kurtzman, NIMH, a grantwriting workshop at the annual meeting of the Gay and Lesbian Medical Association in New Orleans, LA, September 29, 2001. Dr. Cindy Miner presented “Prescription Drug Misuse, Abuse and Addiction” at the CADCA National Leadership Forum, December 13, 2001, Washington, D.C. Dr. Lula Beatty, Chief, Special Populations Office, presented a seminar on research opportunities at NIDA at George Washington University for students and faculty on November 2, 2001. Dr. Lula Beatty presented a session on research funding opportunities at NIDA as part of the colloquia series at the School of Social Work, Howard University, on Nov. 19, 2001. Dr. Lula Beatty presented a session on "Steps to NIH Support" at a meeting sponsored by the NIH Office on AIDS entitled "HIV/AIDS Prevention, Care and Research: Gathering for the Circle of Life" in Albuquerque on January 10, 2002. In December 2001, Dr. Lula Beatty reviewed convention proposal submissions for Divisions 35 (Society for the Psychology of Women) and 45 (Society for the Psychological Study of Ethnic Minority Issues) of the American Psychological Association. In September 2001, Dr. Lula Beatty reviewed conference proposal submissions for the Sixth National Head Start Research Conference. Ana Anders, Senior Advisor on Special Populations, worked with ONDCP, other Federal Agencies (SAMHSA, Dept. of Education, Justice Dept., Dept. of Transportation, etc.) and representatives of the Mexican government on the planning of the U.S./Mexico Binational Drug Demand Reduction annual conference held in Mexico City, Mexico in November 2001. She was responsible for planning and co-chairing the pre-conference Research Symposium. Additionally, she planned and developed research workshops for the Conference Research Track. Ana Anders participated in planning the 2001 national observance of World Health Day with the American Association for World Health, the Pan American Health Organization and other Federal agencies. Ana Anders co-chaired the planning meeting for the Latino Behavioral Health Institute annual conference held in Los Angeles, California in September 2001. Ana Anders, as the NIDA Project Officer of a contractual agreement with the University of Miami, participated in the planning and development of the first national conference of the National Science Network on Drug Abuse held in Washington, D.C., November 2001 Ana Anders, as President of the NIH Hispanic Employee Organization, planned and hosted the Hispanic Heritage Month Observance for the NIH in September 2001. Flair Lindsey, Program Analyst, Special Populations Office, coordinated the fifth annual Summer Research with NIDA program. The program allowed high school and undergraduate students to engage in drug abuse research with NIDA grantees for 8-10 weeks during the summer. In 2001, 40 students and 17 grantees participated in the program. On September 24-26, 2002, Mary Ann Stephens, Ph.D., CCTN, attended and hosted sessions at the Health Disparities Conference in Philadelphia, PA. Dr. Jack Blaine, CCTN, gave a presentation on the CTN at the American Methadone Treatment Association Conference, October 7, 2001, in St. Louis, MO. At that same meeting, several CTN community treatment providers discussed the clinical treatment provider perspective on participating in research and CTN principal investigators discussed overcoming barriers to blending clinical practice and research. Dr. Betty Tai, CCTN, presented on CTN efforts in outreach to Hispanic patient populations and future collaborations with the National Hispanic Science Network on Drug Abuse, November 8-10, 2001, in Washington, D.C., co-sponsored by the Puerto Rico/Virgin Island ATTC. Dr. Mark Swieter, OEA, presented a talk in November at American University in Washington, DC. This talk, addressed to graduate students and faculty in a variety of scientific areas, covered NRSA fellowships, the grants process, and the “do’s and don’ts” of putting together an application. Dr. Rita Liu, Associate Director for Receipt and Referral, OEA, and co-chair of the NIDA Neuroscience Consortium Workgroup, assisted in the organization of a poster session on NIDA program priorities and review issues at the November meeting of the Society for Neuroscience in San Diego. The Office of Extramural Affairs was represented by Drs. Teresa Levitin, Director, OEA; Khursheed Asghar, Chief, Basic Sciences Review Branch; and Rita Liu. Mr. Richard Harrison, Chief, Contracts Review Branch, OEA, provided information and recruitment activities with a NIDA Exhibit Booth for American Indian students at the November meeting of the American Indian Science and Engineering Society held in Albuquerque, NM. Dr. William C. Grace served as a reviewer for HIV research proposals for the National Institute of Allergy and Infectious Diseases Prevention Science Review Committee in November. Drs. William C. Grace, Deputy Director, OEA, Teresa Levitin, Director, OEA, and Susan Coyle, (formerly of OEA) presented “Characteristics of Successfully Recruited Grant Application Peer Reviewers” at the Fourth International Congress on Peer Review in Biomedical Publication held in Barcelona, Spain, September 14-16, 2002. Since air travel disruption precluded the authors’ attendance at this meeting, a poster session displaying their data was presented on their behalf. Dr. Marina Volkov, SRA, Clinical, Epidemiological, and Applied Sciences Review Branch, OEA, presented a talk at City College of the City University of New York. Her talk was titled "Navigating the Bureaucratic Haze: How to Get Funding from NIH," and it was presented on December 10, 2001. Dr. Minda Lynch, BCSRB, DNBR presented on “Club Drugs” to the Montgomery County Alcohol and Other Drug Abuse Advisory Council in January 2001. Dr. Cora Lee Wetherington, DNBR and NIDA’s Women & Gender Research Coordinator, gave the keynote talk, “Developmental Vulnerabilities for Women and Substance Abuse,” in the workshop, “ Women and Substance Abuse” at the California Society of Addiction Medicine: State of the Art in Addiction Medicine meeting in Marina Del Rey, CA, October 19, 2001. Dr. Cora Lee Wetherington served as co-host of the Women and Drug Abuse Special Interest Luncheon Table at the National Hispanic Science Network on Drug Abuse first national conference, Hispanic Drug Abuse Research: Advancing the Field, November 8-10, 2001, Washington, DC. A NIDA sponsored Workshop; “Using Buprenorphine in Office-Based Practice” was held on Monday October 8, 2001 at the American Methadone Treatment Association Meeting in St. Louis, Missouri. This session was organized by Drs. Dorynne Czechowicz, Robert Walsh and Frank Vocci, all of NIDA’s Division of Treatment Research and Development. NIDA sponsored a symposium on the prevention and treatment of adolescent drug abuse at the ASAM state-of –the art conference in November 2001, Washington, D.C. This session was organized by Dorynnne Czechowicz, M.D., DTR&D, in collaboration with the NIDA Child and Adolescent Research Workgroup. On November 16, 2001, at the Association for Advancement of Behavior Therapy meeting in Philadelphia, Dr. Lisa Onken, DTR&D, discussed “Writing Behavioral Treatment Research Grants for NIDA“ at a symposium organized by Steven Beach, Ph.D. on “Writing Grants for NIDA, NIMH, and the CDC.” On November 17, 2001, at the Association for Advancement of Behavior Therapy meeting in Philadelphia, Dr. Lisa Onken, DTR&D, participated in a symposium organized by Linda Dimeff, Ph.D. entitled, “Getting It Out There In A Big Way: Three National Models of Dissemination.” Her presentation was on “Behavioral Treatment Research at NIDA.” Debbie Grossman and Dr. Ivan Montoya, both of DTR&D, represented NIDA at the Youth Tobacco Cessation Collaborative Meeting (YTCC) in Washington, D.C., on December 11, 2001. The YTCC is a collaborative group composed of representatives of major organizations that fund research, program, and policy initiatives related to controlling youth tobacco use. Robert Walsh, DTR&D, presented “Studying Buprenorphine in Office-Based Settings NIDA/VACSP Study #1018”at the NIDA sponsored workshop entitled “Using Buprenorphine in Office-Based Practice” on October 8, 2001, at the American Methadone Treatment Association Meeting in St. Louis, Missouri. Dr. Dorynne Czechowicz, Mr. Robert Walsh and Dr. Frank Vocci, DTR&D organized this session. Dr. Steven Grant, DTR&D, co-chaired a satellite symposium with Drs. David Shurtleff and Herb Weingartner entitled “Neuroscience Perspectives on the Effects of Ecstasy (MDMA)” at the 31st annual meeting of the Society for Neuroscience, San Diego, California November 14, 2001. Speakers at the symposium were Brian Yamamoto, Cleveland VA Medical Center, Annette Fleckenstein, University of Utah, Linda Chang, Brookhaven National Laboratory, Michael Morgan, University of Wales and Glen Hanson, NIDA. Drs. Steven Grant, Harold Gordon, and Joseph Frascella represented the Clinical Neurobiology Branch, DTR&D at the NIDA booth during the Society for Neuroscience Meeting in San Diego, CA, November 12-15, 2001. Drs. Joseph Frascella and Frank Vocci, DTR&D, conducted a session entitled “Strategies for Successful Grant Writing” at the First National Conference Hispanic Drug Abuse Research: Advancing the Field held in Washington, DC, November 8, 2001. Dr. Joseph Frascella, DTR&D, presented a poster on the Institute’s Clinical Neurobiology program at a symposium of the 31st annual meeting of the Society for Neuroscience entitled “Transition from Drug Use to Addiction: Neuroscience Advances and Opportunities”, November 13, 2001 in San Diego, CA. Dr. Steven Grant, DTR&D, co-chaired a symposium with Charles O’Brien, M.D., Ph.D. (University of Pennsylvania) entitled “Transition to Addiction: Does Pushing the Lever Pull the Switch” at the 40th annual meeting of the American College for Neuropsychopharmacology in Waikolola, Hawaii December 8-13, 2001. Speakers at the symposium were James Anthony, Johns Hopkins University, Elliot Stein, Medical College of Wisconsin, Linda Porrino, Wake Forrest University, and Barry Everitt, Cambridge University. In November 2001, Dorynne Czechowicz, M.D., DTR&D, represented the National Institute on Drug Abuse, at a DHHS meeting on International Drug Scheduling. The purpose of this meeting was to discuss the coordination of international scheduling activities among the various Federal agencies. On November 9, 2001, Dr. Lisa Onken, DTR&D, gave a presentation entitled, “Behavioral Treatment Research at NIDA: Opportunities for Hispanic Researchers & Research,” at the meeting of the National Hispanic Science Network on Drug Abuse in Washington, D.C. Dr. Eve Reider, Prevention Research Branch, DESPR, represented NIDA at the Center for Mental Health Services (CMHS)’, Substance Abuse and Mental Health Services Administration, Roundtable on Shared and Unique Perspectives of Evidence-Based Prevention Practices, on October 5, 2001 in Washington, D.C. Dr. Reider represented NIDA at The National Prevention Coalition meeting held on October 9, 2001 held at the National Mental Health Association in Alexandria, Virginia. Dr. Reider represented NIDA at the National Summit, When Terror Strikes: Addressing the Nation’s Mental Health and Substance Abuse Needs- Strengthening the Homeland through Recovery, Resilience and Readiness, sponsored by the U.S. Department of Health and Human Services (DHHS) and Substance Abuse and Mental Health Services Administration (SAMHSA). The summit was held November 14-16, 2001 in New York City. Dr. Reider was the reporter for a roundtable discussion entitled Research, Evaluation, and Best Practices. Dr. Reider represented NIDA at an Interagency Juvenile Justice meeting held November 27, 2001 at Office of National Drug Control Policy (ONDCP) in Washington, D.C. Drs. Liz Robertson, DESPR, and Suman Rao, OSPC, presented a seminar titled Principles of Prevention Research: An Update at the Community Anti-Drug Coalitions of American National Leadership Forum XII, on December 14, 2001, in Washington, D.C. Arnold Mills, DESPR, attended the 53rd Annual Meeting of the American Society of Criminology held in Atlanta, Georgia November 7-10, 2001. He served as the discussant for one of the sessions entitled Drugs and Crime: A National Research Agenda. Moira O’Brien, DESPR, gave a presentation on Brains, Behavior and Culture: Integrating Perspectives on Drug Abuse and Addiction in a National Research Program, and participated in a cross-NIH session on extramural research opportunities during the annual meeting of the American Anthropological Association in Washington, D.C. on December 1, 2001. Dr. Kevin Conway, DESPR, attended the 53rd Annual Meeting of the American Society of Criminology held in Atlanta, Georgia November 7-10, 2001. He presented a paper entitled Substance Use Disorders, Psychopathology, and Reported Violence. Dr. Conway organized a bioethics panel for the NIDA Genetics Consortium Meeting, December 4, 2001. The expert panelists discussed the ethics considerations surrounding issues third parties involved in human genetics research. Dr. Jerry Flanzer, DESPR, gave two lectures, one on the state of health services research regarding adolescent drug abuse treatment and service delivery in 2001, the other on the directions for drug abuse health services research for the next decade at the Health Services Disparities Conference, Galveston, Texas, October 31-November 2, 2001. Dr. Flanzer and Dr. Thomas Hilton, DESPR, represented NIDA at the International Oxford House Conference, Washington, DC, November 30, 2001. Drs. Peter Delany and James Colliver of DESPR conducted briefings on the findings of the 2001 Monitoring the Future Study for the Department of Health and Human Services and the Office of National Drug Control Policy. Dr. Colliver represented NIDA at the annual meeting of the Healthy People 2010 Consortium in Atlanta on October 19, 2001 and gave a presentation on progress toward substance abuse objectives. Dr. Dionne J. Jones, CAMCODA, moderated a workshop entitled “Special Issues to Consider with Substance Abusers” and served as Discussant on a second workshop entitled, “Interventions for At Risk Minority Substance Abusing Women” at the American Public Health Association Annual Meeting in Atlanta, GA, October 22-25, 2001. Dr. Jones chaired a NIDA-sponsored symposium entitled “Drug Abuse, HIV Risk, and HIV Disease in the Brain” at the Annual Meeting of the Society for Neuroscience in San Diego, CA, November 12-15, 2001. Dr. Toni Shippenberg, IRP, was co-chair and presenter of a panel symposia entitled “Opioid-Induced Plasticity From Neuron To The Addict; New Perspectives for the Treatment of Drug Addiction” at the 2001 American College of Neuropharmacology Meeting, December 9-13, 2001, Waikoloa, Hawaii. Dr. Amy Newman, IRP, presented two invited lectures entitled “ A Medicinal Chemistry Strategy in Drug-Abuse Research” and “Novel Probes for the Dopamine Transporter: In Search of a Cocaine-Abuse Therapeutic” at the Department of Chemistry, Northern Arizona University, Flagstaff, AZ, in November 2001.
[Office of the Director][Report Index][Next Report Section]
|
